Is Grade 3 DCIS Considered Breast Cancer?
Yes, ductal carcinoma in situ (DCIS) grade 3 is technically classified as breast cancer—specifically, stage 0 noninvasive breast cancer—but it is fundamentally different from invasive breast cancer in that it is nonlethal and confined within the breast ducts. 1
Understanding the Classification
DCIS represents a noninvasive stage of breast cancer where malignant epithelial cells remain confined within the ductal system by an intact basement membrane, without invasion into surrounding breast tissue 2, 3. The terminology can be confusing for patients because:
- It is called "carcinoma" (cancer) because the cells have undergone malignant transformation with abnormal growth patterns
- It is "in situ" meaning the cancer cells remain in their place of origin and have not invaded
- It is stage 0 in the breast cancer staging system 1
Critical Distinction: Noninvasive vs. Invasive Disease
The most important concept to communicate is that DCIS is a nonlethal type of cancer because it stays in its normal place 2. This fundamentally distinguishes it from invasive breast cancer:
- DCIS itself cannot metastasize or cause death
- It is considered a nonobligate precursor to invasive breast cancer 4, 5
- Only 40% of untreated DCIS lesions progress to invasive disease 4
- Breast cancer-specific survival for DCIS is excellent 6
Grade 3 DCIS: Higher Risk Features
Grade 3 (poorly differentiated) DCIS does carry specific implications:
- If progression occurs, grade 3 DCIS frequently gives rise to grade III invasive breast cancer 6
- Grade 3 lesions demonstrate larger nuclear area, aneuploid DNA, and abundant vascular neogenesis, confirming more aggressive patterns than lower grades 7
- These tumors show progressively increased microvessel density and proliferative markers compared to grades 1 and 2 7
Treatment Implications
Despite being noninvasive, DCIS requires treatment because:
- The goal is preventing progression to invasive disease or detecting any invasive component early 1
- Treatment options include breast-conserving surgery with or without radiation, or mastectomy 8
- Local recurrence rates differ by treatment approach, but overall survival remains excellent regardless of surgical choice 8
- If any invasive component is found on pathology review or re-excision, the patient must be treated according to invasive breast cancer guidelines 1
Common Pitfall to Avoid
Do not equate DCIS with invasive breast cancer when discussing prognosis and mortality risk. While DCIS is technically "breast cancer" by classification, patients need to understand that:
- The prognosis is excellent with appropriate treatment
- The disease is not immediately life-threatening
- Treatment focuses on prevention rather than treating metastatic potential
- The 1-2% relapse rate after mastectomy is due to unrecognized invasive foci, not the DCIS itself 8
In summary: Grade 3 DCIS is classified as stage 0 breast cancer, but it is a noninvasive precursor lesion with excellent prognosis when treated appropriately, fundamentally different from invasive breast cancer in terms of mortality risk.